News

How the Biological Clock Ticks in the Female Reproductive Tract – Breakthrough of the Year Award 2025 for Ângela Gonçalves

_{11/07/2025 | by Koh}
Endometriosis, ovarian cancer, menopause – still under-researched and often misdiagnosed. Ângela Gonçalves combines AI, molecular biology, and clinical insights to develop strategies for early detection, personalized care, and healthier aging – directly challenging gender bias in medicine. The researcher from the DKFZ Hector Cancer Institute at University Medicine Mannheim has been honored with the Breakthrough of the Year 2025 in the Women’s Impact category by the Falling Walls Foundation.

Role of intestinal bacteria in the development of colorectal cancer: Emmy Noether grant for DKFZ researcher Jens Puschhof

10/27/2025 | by Koh

The German Research Foundation (DFG) is funding a new Emmy Noether project led by Jens Puschhof from the German Cancer Research Center (DKFZ). With this project, the junior researcher aims to decipher the role of certain intestinal bacteria in the earliest stages of colorectal cancer development and investigate how this process can be halted. The long-term goal is to develop new preventive strategies against colorectal cancer.

Prestigious DFG funding for DKFZ projects

10/14/2025 | by Koh

The Reinhart Koselleck Program of the German Research Foundation (DFG) aims to give researchers with outstanding achievements the opportunity to carry out highly innovative and positively risk-taking projects. This year, two projects from the German Cancer Research Center (DKFZ) are receiving this prestigious funding.

Mannheim to lead Nnew DFG research unit

09/26/2025

The German Research Foundation (DFG) is funding a collaborative project that focuses on functional genomics and microbiomics in colorectal cancer.

In the latest funding round of the DFG, the Medical Faculty Mannheim of Heidelberg University was successful with its proposal for a new research unit in the field of oncology. The newly established research consortium GenoMiCC pursues a promising approach to identify novel targets for personalized colorectal cancer therapy through functional genomics and microbiomics. Over a period of four years, the DFG, together with the Swiss National Science Foundation (SNSF), will provide 5.8 million euros in funding as part of the D-A-CH collaboration.